{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:33:55Z","timestamp":1762875235971},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s12272-009-1311-1","type":"journal-article","created":{"date-parts":[[2009,4,22]],"date-time":"2009-04-22T05:48:14Z","timestamp":1240379294000},"page":"383-389","source":"Crossref","is-referenced-by-count":7,"title":["Serologic response to human papillomavirus type 16 virus-like particles in Korean women with cervical precancerous and cancerous lesions"],"prefix":"10.1007","volume":"32","author":[{"given":"Nan-Hee","family":"Jeong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nak-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Kyung","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,4,23]]},"reference":[{"key":"1311_CR1","doi-asserted-by":"crossref","unstructured":"Bosch, F. X. and De Sanjose, S., Chapter 1: Human papillomavirus and cervical cancer\u2014burden and assessment of causality. J Natl Cancer Inst Monogr, 3\u201313 (2003).","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479"},{"key":"1311_CR2","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1086\/315498","volume":"181","author":"J. J. Carter","year":"2000","unstructured":"Carter, J. J., Koutsky, L. A., Hughes, J. P., Lee, S. K., Kuypers, J., Kiviat, N., and Galloway, D. A., Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis, 181, 1911\u20131919 (2000).","journal-title":"J Infect Dis"},{"key":"1311_CR3","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/infdis\/174.5.927","volume":"174","author":"J. J. Carter","year":"1996","unstructured":"Carter, J. J., Koutsky, L. A., Wipf, G. C., Christensen, N. D., Lee, S. K., Kuypers, J., Kiviat, N., and Galloway, D. A., The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis, 174, 927\u2013936 (1996).","journal-title":"J Infect Dis"},{"key":"1311_CR4","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/j.1525-1438.2006.00708.x","volume":"16","author":"H. H. Chung","year":"2006","unstructured":"Chung, H. H., Jang, M. J., Jung, K. W., Won, Y. J., Shin, H. R., Kim, J. W., and Lee, H. P., Cervical cancer incidence and survival in Korea: 1993\u20132002. Int J Gynecol Cancer, 16, 1833\u20131838 (2006).","journal-title":"Int J Gynecol Cancer"},{"key":"1311_CR5","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1158\/1055-9965.EPI-07-0349","volume":"16","author":"G. M. Clifford","year":"2007","unstructured":"Clifford, G. M., Shin, H. R., Oh, J. K., Waterboer, T., Ju, Y. H., Vaccarella, S., Quint, W., Pawlita, M., and Franceschi, S., Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea. Cancer Epidemiol Biomarkers Prev, 16, 1874\u20131879 (2007).","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1311_CR6","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ijc.10153","volume":"97","author":"A. L. Combita","year":"2002","unstructured":"Combita, A. L., Bravo, M. M., Touze, A., Orozco, O., and Coursaget, P., Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 viruslike particles in colombian women with invasive cervical cancer. Int J Cancer, 97, 796\u2013803 (2002).","journal-title":"Int J Cancer"},{"key":"1311_CR7","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jnci\/89.9.630","volume":"89","author":"T. D. Gruijl De","year":"1997","unstructured":"De Gruijl, T. D., Bontkes, H. J., Walboomers, J. M., Schiller, J. T., Stukart, M. J., Groot, B. S., Chabaud, M. M., Remmink, A. J., Verheijen, R. H., Helmerhorst, T. J., Meijer, C. J., and Scheper, R. J., Immunoglobulin G responses against human papillomavirus type 16 viruslike particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia. J Natl Cancer Inst, 89, 630\u2013638 (1997).","journal-title":"J Natl Cancer Inst"},{"key":"1311_CR8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/scbi.1999.0146","volume":"9","author":"J. Dillner","year":"1999","unstructured":"Dillner, J., The serological response to papillomaviruses. Semin Cancer Biol, 9, 423\u2013430 (1999).","journal-title":"Semin Cancer Biol"},{"key":"1311_CR9","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1086\/430274","volume":"191","author":"E. F. Dunne","year":"2005","unstructured":"Dunne, E. F., Karem, K. L., Sternberg, M. R., Stone, K. M., Unger, E. R., Reeves, W. C., and Markowitz, L. E., Seroprevalence of human papillomavirus type 16 in children. J Infect Dis, 191, 1817\u20131819 (2005).","journal-title":"J Infect Dis"},{"key":"1311_CR10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ijc.22176","volume":"120","author":"M. H. Einstein","year":"2007","unstructured":"Einstein, M. H., Studentsov, Y. Y., Ho, G. Y., Fazzari, M., Marks, M., Kadish, A. S., Goldberg, G. L., Runowicz, C. D., and Burk, R. D., Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia. Int J Cancer, 120, 55\u201359 (2007).","journal-title":"Int J Cancer"},{"key":"1311_CR11","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ajog.2004.09.130","volume":"192","author":"K. Heim","year":"2005","unstructured":"Heim, K., Widschwendter, A., Szedenik, H., Geier, A., Christensen, N. D., Bergant, A., Concin, N., and Hopfl, R., Specific serologic response to genital human papillomavirus types in patients with vulvar precancerous and cancerous lesions. Am J Obstet Gynecol, 192, 1073\u20131083 (2005).","journal-title":"Am J Obstet Gynecol"},{"key":"1311_CR12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","volume":"338","author":"G. Y. Ho","year":"1998","unstructured":"Ho, G. Y., Bierman, R., Beardsley, L., Chang, C. J., and Burk, R. D., Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med, 338, 423\u2013428 (1998).","journal-title":"N Engl J Med"},{"key":"1311_CR13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/342972","volume":"186","author":"G. Y. Ho","year":"2002","unstructured":"Ho, G. Y., Studentsov, Y., Hall, C. B., Bierman, R., Beardsley, L., Lempa, M., and Burk, R. D., Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 viruslike particles. J Infect Dis, 186, 737\u2013742 (2002).","journal-title":"J Infect Dis"},{"key":"1311_CR14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3802\/kjgoc.2004.15.4.309","volume":"15","author":"W. D. Joo","year":"2004","unstructured":"Joo, W. D., Joo, W. D., Kim, S. H., Kim, S. H., Kim, D. Y., Kim, D. Y., Suh, D. S., Suh, D. S., Kim, J. H., Kim, J. H., Kim, Y. M., Kim, Y. M., Kim, Y. T., Kim, Y. T., Mok, J. E., Mok, J. E., Nam, J. H., and Nam, J. H., Prevalence of human papillomavirus infection in Korean women: Risks of abnormal pap smear and cervical neoplasia. Korean J Gynecol Oncol Colposc, 15, 309\u2013316 (2004).","journal-title":"Korean J Gynecol Oncol Colposc"},{"key":"1311_CR15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pep.2008.01.021","volume":"59","author":"H. J. Kim","year":"2008","unstructured":"Kim, H. J., Park, M. A., and Kim, H. J., Optimum conditions for production and purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae. Protein Expr. Purif., 59, 175\u2013181 (2008)","journal-title":"Protein Expr. Purif."},{"key":"1311_CR16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jviromet.2006.09.004","volume":"139","author":"S. N. Kim","year":"2007","unstructured":"Kim, S. N., Jeong, H. S., Park, S. N., and Kim, H. J., Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae. J Virol Methods, 139, 24\u201330 (2007).","journal-title":"J Virol Methods"},{"key":"1311_CR17","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/jnci\/86.7.494","volume":"86","author":"R. Kirnbauer","year":"1994","unstructured":"Kirnbauer, R., Hubbert, N. L., Wheeler, C. M., Becker, T. M., Lowy, D. R., and Schiller, J. T., A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst, 86, 494\u2013499 (1994).","journal-title":"J Natl Cancer Inst"},{"key":"1311_CR18","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1128\/JCM.33.5.1380-1382.1995","volume":"33","author":"P. Cann Le","year":"1995","unstructured":"Le Cann, P., Touze, A., Enogat, N., Leboulleux, D., Mougin, C., Legrand, M. C., Calvet, C., Afoutou, J. M., and Coursaget, P., Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus. J Clin Microbiol, 33, 1380\u20131382 (1995).","journal-title":"J Clin Microbiol"},{"key":"1311_CR19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0025-7753(03)73988-8","volume":"121","author":"N. Munoz","year":"2003","unstructured":"Munoz, N., Value of human papilloma virus testing in the diagnosis and screening of cervical neoplasia. Med Clin (Barc), 121, 455\u2013456 (2003).","journal-title":"Med Clin (Barc)"},{"key":"1311_CR20","first-page":"176","volume":"39","author":"J. S. Park","year":"1996","unstructured":"Park, J. S., Hwang, E. S., Ahn, H. K., Kim, C. J., Jung, G. T., Kim, H. S., Park, S. H., Namkoong, S. E., Kim, S. J., Seroreactivities to HPV-16 Virus Like Particles (VLPs) using ELISA in the patients with cervical neoplasia. Korean J Obstet Gynecol, 39, 176\u2013185 (1996).","journal-title":"Korean J Obstet Gynecol"},{"key":"1311_CR21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/gyno.1998.4963","volume":"69","author":"J. S. Park","year":"1998","unstructured":"Park, J. S., Park, D. C., Kim, C. J., Ahn, H. K., Um, S. J., Park, S. N., Kim, S. J., and Namkoong, S. E., HPV-16-related proteins as the serologic markers in cervical neoplasia. Gynecol Oncol, 69, 47\u201355 (1998).","journal-title":"Gynecol Oncol"},{"key":"1311_CR22","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/jcp.50.7.600","volume":"50","author":"L. Pirami","year":"1997","unstructured":"Pirami, L., Giache, V., and Becciolini, A., Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. J Clin Pathol, 50, 600\u2013604 (1997).","journal-title":"J Clin Pathol"},{"key":"1311_CR23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<529::AID-IJC7>3.0.CO;2-V","volume":"75","author":"T. Sasagawa","year":"1998","unstructured":"Sasagawa, T., Yamazaki, H., Dong, Y. Z., Satake, S., Tateno, M., and Inoue, M., Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions. Int J Cancer, 75, 529\u2013535 (1998).","journal-title":"Int J Cancer"},{"key":"1311_CR24","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/jnci\/85.12.958","volume":"85","author":"M. H. Schiffman","year":"1993","unstructured":"Schiffman, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. B., Scott, D. R., Sherman, M. E., Kurman, R. J., Wacholder, S., and Et Al., Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst, 85, 958\u2013964 (1993).","journal-title":"J Natl Cancer Inst"},{"key":"1311_CR25","first-page":"4921","volume":"26","author":"D. Skiba","year":"2006","unstructured":"Skiba, D., Mehlhorn, G., Fasching, P. A., Beckmann, M. W., and Ackermann, S., Prognostic significance of serum antibodies to HPV-16 L1 virus-like particles in patients with invasive cervical cancer. Anticancer Res, 26, 4921\u20134926 (2006).","journal-title":"Anticancer Res"},{"key":"1311_CR26","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1086\/344354","volume":"186","author":"K. M. Stone","year":"2002","unstructured":"Stone, K. M., Karem, K. L., Sternberg, M. R., Mcquillan, G. M., Poon, A. D., Unger, E. R., and Reeves, W. C., Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis, 186, 1396\u20131402 (2002).","journal-title":"J Infect Dis"},{"key":"1311_CR27","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/315055","volume":"180","author":"L. Wideroff","year":"1999","unstructured":"Wideroff, L., Schiffman, M., Haderer, P., Armstrong, A., Greer, C. E., Manos, M. M., Burk, R. D., Scott, D. R., Sherman, M. E., Schiller, J. T., Hoover, R. N., Tarone, R. E., and Kirnbauer, R., Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions. J Infect Dis, 180, 1424\u20131428 (1999).","journal-title":"J Infect Dis"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-009-1311-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-009-1311-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-009-1311-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T17:12:25Z","timestamp":1589735545000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-009-1311-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["1311"],"URL":"https:\/\/doi.org\/10.1007\/s12272-009-1311-1","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}